References
- National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Vascular access, update 2006. Am J Kidney Dis. 2006;48(Suppl 1):S177–S247.
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
- Bahadi A, Hamzi MA, Farouki MR, et al. Predictors of early vascular-access failure in patients on hemodialysis. Saudi J Kidney Dis Transpl. 2012;23:83–87.
- Shen B, Zhang W, Tian SM, et al. Clinical analysis of chronic renal failure patients with arteriovenous fistula thrombosis in hemodialysis. J Prac Med. 2005;21:67–68.
- Zhang ZM, Chen SY, Zhang WX, et al. Clinical analysis on application of arteriovenous fistula in maintenance hemodialysis patients. Chin J Blood Purif. 2007;6:312–313.
- Liao YL, Qin WY, Lan XL, et al. Analysis of related factors of thrombosis in Autogenous arteriovenous fistula. Chinese Youjiang Med J. 2015;43:444–446.
- Jiang Y. Analysis of risk factors of autologous internal arteriovenous fistula thrombosis. Med J Natl Defend Forces Southwest China. 2013;23:1078–1081.
- Hu DJ, Liu PN, Yin NH, et al. Influential factor analysis of arteriovenous fistula re-thrombosis in hemodialysis patients. Guangdong Med J. 2014;35:677–680.
- Zhang YL, Zhao JY, Dong ZB, et al. Clinical analysis on status of arterioveneous fistula occlusion in hemodialysis patients. Chinese J Dial Artif Organs. 2010;21: 31–33.
- Afsar B, Elsurer R. The primary arteriovenous fistula failure – a comparison between diabetic and non-diabetic patients: glycemic control matters. Int Urol Nephrol. 2012;44:575–581.
- Fekih-Mrissa N, Klai S, Bafoun A, et al. Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia. Ther Apher Dial. 2011;15:40–43.
- Roozbeh J, Serati A-R, Malekhoseini S-A. Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients. Arch Iran Med. 2006;9:26–32.
- Moon J-Y, Lee HM, Lee S-H, et al. Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis. Kidney Res Clin Pract. 2015;34:41–46.
- Manns BJ, Burgess ED, Parsons HG, et al. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int. 1999;55:315–320.
- Shemin D, Lapane KL, Bausserman L, et al. Plasma total homocysteine and hemodialysis access thrombosis. J Am Soc Nephrol. 1999;10:1095–1099.
- Usta E, Elkrinawi R, Salehi-Gilani S, et al. Risk factors predicting the successful function and use of autogenous arteriovenous fistulae for hemodialysis. Thorac Cardiovasc Surg. 2013;61:438–444.
- Yao SL, Benedetto F, Mondello P, et al. Related factors of autologous arteriovenous fistula in early functional and nursing intervention measures. Journal of Qilu Nursing | J Qilu Nurs. 2015;21:43–45.
- Li ZZ, Gohil R, Chetter IC, et al. Analysis of factors relating to the dysfunction in Autogenous Arteriovenous Fistulae in maintenance Hemodialysis. Cjitwn. 2014;15:961–964.
- Wang YZ. The analysis of the relative factors inducing stenosis of native arteriovenous fistula (AVF) in maintaining hemodialysis patients. Chinese J Misdiagnos Tics. 2005;5:213–215.
- Zhong HY, Wang YQ, Wu FJ, et al. Related factors of autologous arteriovenous fistula dysfunction. Guangdong Med J. 2010;31:3249–3251.
- Chen MX. Analysis and interventionIn in maintenance hemodialysis patients with arteriovenous fistula. Guide China Med. 2015;13:74–75.
- Wei XH, Feng SH, Wei SH, et al. Analysis of dysfnction of aative arteriovenous fistula in maintaining hemodialysis patients. GuangXi Med J. 2015;37:848–854.
- Cui TL, Zhang RZ, Liu F, et al. Association of diabetes and early failure of arteriovenous fistulae in the end stage of renal disease. Med Sci Edi. 2012;453:438–441.
- He Q, Li GS, Kang ZM, et al. Research on the factors affecting the maturation of arteriovenous fistula. Chin J Blood Purif. 2009;7:369–371.
- Danis R, Ozmen, S, Akin, D, et al. Thrombophilias and arteriovenous fistula dysfunction in maintenance hemodialysis. J Thromb Thrombolysis. 2009;27:307–315.
- Reddy MA, Tak Park J, Natarajan R, et al. Epigenetic modifications in the pathogenesis of diabetic nephropathy. Semin Nephrol. 2013;33:341–353.
- Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527–1532.
- Gołębiowski T, Weyde W, Kusztal, M, et al. Vascular access in diabetic patients. Are these patients “difficult”? Postepy Hig Med Dosw. 2015;69:913–917.
- Yasuhara H, Shigematsu H, Muto T, et al. Results of arteriovenous fistula revision in the forearm. Am J Surg. 1997;174:83–86.
- Li HY. Study of the postoperative nursing for patients with diabetic nephropathy underwent arteriovenous internal fistula surgery. Diabetes New World. 2015;4:231.